Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Barlow, Peter G ^a,d   Svoboda, Pavel ^a   Mackellar, Annie ^b   Nash, Anthony A ^c   York, Ian A ^a   Pohl, Jan ^a   Davidson, Donald J ^b   Donis, Ruben O ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; ZANAMIVIR; ANTIMICROBIAL CATIONIC PEPTIDE; ANTIVIRUS AGENT; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A; ISOMER; MOUSE; NONHUMAN; TREATMENT RESPONSE; VIRUS REPLICATION; VIRUS TITRATION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DOG; HUMAN; IMMUNOLOGY; LUNG; METABOLISM; ORTHOMYXOVIRUS INFECTION; VIROLOGY;

ANIMALIA; INFLUENZA A VIRUS; MURINAE; MUS; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTIVIRAL AGENTS; CELL LINE; DOGS; FEMALE; HUMANS; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 80054841451     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025333     Document Type: Article

References (62)

1. Wu S, Metcalf JP, Wu W, (2011) Innate immune response to influenza virus. Curr Opin Infect Dis.
2. Salvatore M, Garcia-Sastre A, Ruchala P, Lehrer RI, Chang T, et al. (2007) alpha-Defensin Inhibits Influenza Virus Replication by Cell-Mediated Mechanism(s). J Infect Dis 196: 835-843.
3. Tecle T, White MR, Gantz D, Crouch EC, Hartshorn KL, (2007) Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. J Immunol 178: 8046-8052.
4. Bowdish DM, Davidson DJ, Hancock RE, (2006) Immunomodulatory properties of defensins and cathelicidins. Curr Top Microbiol Immunol 306: 27-66.
5. Lai Y, Gallo RL, (2009) AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30: 131-141.
6. Gordon YJ, Huang LC, Romanowski EG, Yates KA, Proske RJ, et al. (2005) Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res 30: 385-394.
7. Yasin B, Pang M, Turner JS, Cho Y, Dinh NN, et al. (2000) Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Eur J Clin Microbiol Infect Dis 19: 187-194.
8. Agerberth B, Gudmundsson GH, (2006) Host antimicrobial defence peptides in human disease. Curr Top Microbiol Immunol 306: 67-90.
9. Steinstraesser L, Tippler B, Mertens J, Lamme E, Homann HH, et al. (2005) Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides. Retrovirology 2: 2.
10. Bergman P, Walter-Jallow L, Broliden K, Agerberth B, Soderlund J, (2007) The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 5: 410-415.
11. Morrison G, Kilanowski F, Davidson D, Dorin J, (2002) Characterization of the mouse Beta defensin 1, defb1, mutant mouse model. Infect Immun 70: 3053-3060.
12. Moser C, Weiner DJ, Lysenko E, Bals R, Weiser JN, et al. (2002) beta-Defensin 1 Contributes to Pulmonary Innate Immunity in Mice. Infect Immun 70: 3068-3072.
13. Putsep K, Carlsson G, Boman HG, Andersson M, (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360: 1144-1149.
14. Huang LC, Reins RY, Gallo RL, McDermott AM, (2007) Cathelicidin-deficient (Cnlp-/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 48: 4498-4508.
15. Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, et al. (2005) Cathelicidin Mediates Innate Intestinal Defense against Colonization with Epithelial Adherent Bacterial Pathogens. J Immunol 174: 4901-4907.
16. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457.
17. Yu FS, Cornicelli MD, Kovach MA, Newstead MW, Zeng X, et al. (2010) Flagellin Stimulates Protective Lung Mucosal Immunity: Role of Cathelicidin-Related Antimicrobial Peptide. J Immunol 185: 1142-1149.
18. Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, et al. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12: 636-641.
19. Zanetti M, (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75: 39-48.
20. Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, et al. (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97: 3951-3959.
21. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
22. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, et al. (2008) Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 181: 7090-7099.
23. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, et al. (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173: 2909-2912.
24. Sabetta JR, Depetrillo P, Cipriani RJ, Smardin J, Burns LA, et al. (2010) Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 5: e11088.
25. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, et al. (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr.
26. Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, et al. (2004) Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol 172: 1763-1767.
27. Bals R, Weiner DJ, Moscioni AD, Meegalla RL, Wilson JM, (1999) Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun 67: 6084-6089.
28. Benincasa M, Skerlavaj B, Gennaro R, Pellegrini A, Zanetti M, (2003) In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs. Peptides 24: 1723-1731.
29. Ryan LK, Dai J, Yin Z, Megjugorac N, Uhlhorn V, et al. (2011) Modulation of human {beta}-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and epithelial cells by influenza virus, Herpes simplex virus, and Sendai virus and its possible role in innate immunity. J Leukoc Biol 90: 343-356.
30. Fortney K, Totten PA, Lehrer RI, Spinola SM, (1998) Haemophilus ducreyi is susceptible to protegrin. Antimicrob Agents Chemother 42: 2690-2693.
31. Yasin B, Harwig SS, Lehrer RI, Wagar EA, (1996) Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect Immun 64: 709-713.
32. Cheung QC, Turner PV, Song C, Wu D, Cai HY, et al. (2008) Enhanced resistance to bacterial infection in protegrin-1 transgenic mice. Antimicrob Agents Chemother 52: 1812-1819.
33. Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, et al. (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192: 1069-1074.
34. Soehnlein O, Zernecke A, Eriksson EE, Rothfuchs AG, Pham CT, et al. (2008) Neutrophil secretion products pave the way for inflammatory monocytes. Blood 112: 1461-1471.
35. Zhang Z, Cherryholmes G, Chang F, Rose DM, Schraufstatter I, et al. (2009) Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils. Eur J Immunol 39: 3181-3194.
36. Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock RE, (2002) The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol 169: 3883-3891.
37. Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, et al. (2003) The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor. J Immunol 171: 6690-6696.
38. Alalwani MS, Sierigk J, Herr C, Pinkenburg O, Gallo R, et al. (2010) The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur J Immunol 40: 1118-1126.
39. Li HN, Barlow PG, Bylund J, Mackellar A, Bjorstad A, et al. (2009) Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages. J Leukoc Biol 86: 891-902.
40. Zhang Z, Cherryholmes G, Shively JE, (2008) Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. J Leukoc Biol 84: 780-788.
41. Bjorstad A, Askarieh G, Brown KL, Christenson K, Forsman H, et al. (2009) The Host Defence Peptide Ll-37 Selectively Permeabilises Apoptotic Leukocytes. Antimicrob Agents Chemother 53: 1027-1038.
42. Barlow PG, Beaumont PE, Cosseau C, Mackellar A, Wilkinson TS, et al. (2010) The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. Am J Respir Cell Mol Biol 43: 692-702.
43. Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, et al. (2009) Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6: 231-243.
44. Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, et al. (2004) The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 172: 1146-1156.
45. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, et al. (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564-569.
46. Elssner A, Duncan M, Gavrilin M, Wewers MD, (2004) A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol 172: 4987-4994.
47. Mookherjee N, Brown KL, Bowdish DM, Doria S, Falsafi R, et al. (2006) Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-37. J Immunol 176: 2455-2464.
48. Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, et al. (2001) Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol 167: 3329-3338.
49. Yu J, Mookherjee N, Wee K, Bowdish DM, Pistolic J, et al. (2007) Host Defense Peptide LL-37, in Synergy with Inflammatory Mediator IL-1beta, Augments Immune Responses by Multiple Pathways. J Immunol 179: 7684-7691.
50. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, et al. (2009) The NLRP3 inflammasome mediates in vivo innate immunity to influenza a virus through recognition of viral RNA. Immunity 30: 556-565.
51. Thomas PG, Dash P, Aldridge JR Jr, Ellebedy AH, Reynolds C, et al. (2009) The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30: 566-575.
52. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A, (2009) Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206: 79-87.
53. Pirhonen J, Sareneva T, Kurimoto M, Julkunen I, Matikainen S, (1999) Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J Immunol 162: 7322-7329.
54. Hale BG, Randall RE, Ortin J, Jackson D, (2008) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89: 2359-2376.
55. Stasakova J, Ferko B, Kittel C, Sereinig S, Romanova J, et al. (2005) Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. J Gen Virol 86: 185-195.
56. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, et al. (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581.
57. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-1207.
58. Chen CI, Schaller-Bals S, Paul KP, Wahn U, Bals R, (2004) Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J Cyst Fibros 3: 45-50.
59. Schaller-Bals S, Schulze A, Bals R, (2002) Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am J Respir Crit Care Med 165: 992-995.
60. Doss M, White MR, Tecle T, Gantz D, Crouch EC, et al. (2009) Interactions of {alpha}-, {beta}-, and {theta}-Defensins with Influenza A Virus and Surfactant Protein D. J Immunol 182: 7878-7887.
61. WHO (2002) WHO manual on animal influenza diagnosis and surveillance.
62. Zughaier SM, Svoboda P, Pohl J, Stephens DS, Shafer WM, (2010) The human host defense peptide LL-37 interacts with Neisseria meningitidis capsular polysaccharides and inhibits inflammatory mediators release. PLoS One 5: e13627.